A localised skin reaction after chemotherapy
Treatment of radiation recall dermatitis involves skin care management with emollients and dressings, analgesia, sun protection, and delay or suspension of the chemotherapeutic drug. [...]a shorter time between radiotherapy and chemotherapy, or high doses of radiation or chemotherapeutic agent might...
Gespeichert in:
Veröffentlicht in: | BMJ (Online) 2018-03, Vol.360, p.k469-k469 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Treatment of radiation recall dermatitis involves skin care management with emollients and dressings, analgesia, sun protection, and delay or suspension of the chemotherapeutic drug. [...]a shorter time between radiotherapy and chemotherapy, or high doses of radiation or chemotherapeutic agent might incur a higher risk of radiation recall dermatitis. 4 There is also evidence that several targeted agents, including mTOR inhibitors and epidermal growth factor inhibitors, are associated with radiation recall reaction. 5 There are case reports of radiation pneumonitis triggered by the immunotherapy drug nivolumab, two years after radiotherapy, 6 and nivolumab induced radiation recall pneumonitis after two years of radiotherapy. 7 Non-cutaneous radiation recall reactions can occur in any organ system. Treatment of radiation recall dermatitis involves skin care management with emollients and dressings, analgesia, sun protection, and delay or suspension of the chemotherapeutic drug. |
---|---|
ISSN: | 0959-8138 1756-1833 |
DOI: | 10.1136/bmj.k469 |